1. Introduction {#sec1}
===============

*Shankhpushpi* has been recognized in Ayurveda as '*Medhya Rasayana*'-- meaning a drug which rejuvenates, maintains and potentiates intellect and memory. On the basis of flower shape and their ability to treat memory related dysfunctions, four botanicals viz. *Canscora decussata* Schult. (CD) (Gentianaceae), *Clitorea ternatea* Linn. (CT) (Leguminosae), *Convolvulus pluricaulis* Choisy. (CP) (Convulvulaceae), and *Evolvulus alsinoides* Linn. (EA) (Convulvulaceae) are considered as *Shankhpushpi* by Indian practitioners [@bib1], [@bib2].

Different varieties of *Shankhpushpi* have proved their curative potential individually in studies related to CNS depression [@bib3], [@bib4], anxiolytic [@bib5], anti-amensic [@bib6], [@bib7], tranquilizing, anti-depressant, anti-stress, neurodegenerative, antioxidant, hypolipidemic, immunomodulatory, analgesic, anti-fungal, anti-bacterial, anti-diabetic, anti-ulcer, anti-catatonic and cardiovascular activity. Several types of alkaloids, terpenoids, phenolics, flavonoids and coumarins are reported as active chemicals responsible for biological effects [@bib8].

*Shankhpushpi* (in various dosage forms) is one of the widely marketed herbal products in India for boosting memory and intellect [@bib9]. Controversy arises due to synonymous names of different available varieties often leading to selection of plant material with poor neuropharmacological activity, which results a less potent formulation. There are some previous studies as well, related to simultaneous evaluation of nootropic, anxiolytic and CNS-depressant activities on two or three varieties of *Shankhpushpi* [@bib10], [@bib11], [@bib12], [@bib13], [@bib14], [@bib15]. Moreover, authors have also done similar studies in the past focusing on anxiolytic and memory enhancement activities of different varieties of *Shankhpushpi* [@bib4], [@bib5], [@bib6], [@bib7]. However, till date none of the studies (including our previous studies) simultaneously evaluated the complete neuropharmacological profile of four varieties, which has been done in the present work by the authors. This helped us to arrive at a conclusion as to which of them is the best in terms of neuropharmacological activity. Various parameters such as *in vitro* protection against β-amyloid induced neurotoxicity on brain cell line (Neuro 2A), antioxidant potential, AchE inhibition, 5-LOX enzyme inhibition, and *in vivo* experiments such as scopolamine induced memory retrieval using pole climbing apparatus and Morris water maze task in rats were performed.

2. Materials and methods {#sec2}
========================

2.1. Chemicals and reagents {#sec2.1}
---------------------------

Eagle's Minimum Essential Medium (EMEM); Earle\'s BSS (Balanced Salt Solution); 2, 2-Diphenyl-1-picryl-hydrazyl (DPPH) (Himedia Laboratories Pvt. Ltd., Mumbai, India). Methylthiazol tetrazolium (MTT) (3-\[4, 5-dimethyIthiazol-2-yl\]-2, 5-diphenyltetra-zolium bromide); β-amyloid (1--40); Acetylthiocholine iodide (ATCI); acetylcholinesterase enzyme (AchE) from human erythrocyte; 5, 5-dithiobis \[2-nitrobenzoic acid\] (DTNB); galantamine; lipoxidase enzyme and linoleic acid were obtained from Sigma Ltd. (Mumbai, India). Ascorbic acid was procured from Loba Chemie (Mumbai, India). Scopolamine (99.98% pure) was obtained as a gift from Cadila Healthcare Pvt. Ltd. (Goa, India). Scopolamine was dissolved in normal saline for i.p. injection. All the chemicals and reagents used in the experiments were of analytical grade. Pre-coated silica gel 60F~254~ TLC plates were purchased from Merck (Darmstadt, Germany).

2.2. Plant materials and preparation of extracts {#sec2.2}
------------------------------------------------

*C. decussata* (CD) was collected from Ninai ghat (Gujarat, India) and identified by Dr S.C. Agrawal (Department of Botany, CDRI, Lucknow, India). *C. ternatea* (CT), *C. pluricaulis* (CP) and *E. alsinoides* (EA) were collected from the outskirts of Vadodara and identified in the Botany Department of M. S. University of Baroda, Vadodara, Gujarat (India). Voucher specimens of all four plants (No. Pharmacy/CD/09-10/13/NS, Pharmacy/CT/09-10/12/NS, Pharmacy/CP/09-10/11/NS, and Pharmacy/EA/09-10/10/NS) have been deposited in the Herbal Drug Technology Lab, Pharmacy Department of the University. 1000 g shade dried and coarsely powdered whole herb of all the drugs was subjected to Soxhlet extraction with methanol. The solvent was completely removed under reduced pressure using rotary evaporator. The percent yield of methanol extract (ME) were found to be 15.78 ± 0.01, 7.31 ± 0.06, 9.56 ± 0.03 and 10.36 ± 0.07% for CD, CT, CP and EA respectively.

2.3. Characterization of extract {#sec2.3}
--------------------------------

High Performance Thin Layer Chromatography (HPTLC) studies were performed using various solvent systems as reported in our earlier studies [@bib9], [@bib15], [@bib16], [@bib17].

2.4. Experimental procedure {#sec2.4}
---------------------------

### 2.4.1. *In vitro* neuropharmacological studies {#sec2.4.1}

#### 2.4.1.1. β-amyloid induced neuroprotection on brain cell line {#sec2.4.1.1}

##### 2.4.1.1.1. Cell culture and stock solutions {#sec2.4.1.1.1}

Neuro-2a (a neuroblastoma cell line) was obtained from the National Centre for Cell Sciences (NCCS), Pune, India and routinely cultured in EMEM supplemented with 10% (v/v) fetal bovine serum (FBS), gentamicin (50 μg/ml) and amphotericin B (2.5 μg/ml) in 10% CO~2~/90% humidified air at 37 °C. Neuro-2A was split in 96-well plates at a concentration of 1 × 10^5^ cells per ml and allowed to adhere for 24 h at 37 °C. The toxicity of Aβ on Neuro-2a cells was assessed by MTT assay. Briefly, Neuro-2a cells were exposed to Aβ~1--40~ (0.1 μM, 0.5 μM, 1 μM, 5 μM, 10 μM and 15 μM) for 24 h and the rate of MTT reduction was recorded [@bib18]. After assessment of toxicity, Neuro-2a with (10 μM) or without Aβ~1--40~ (dissolved in pyrogen free water) plus different concentrations (10 μM, 20 μM, 30 μM, 50 μM, 100 μM and 200 μM) of methanol extract of *Shankhpushpi* botanicals viz. MECD, MECT, MECP, MEEA were diluted in DMSO. The final DMSO concentration in each sample was 0.1%, and this concentration did not affect cell growth or death.

##### 2.4.1.1.2. MTT cell viability assay {#sec2.4.1.1.2}

A MTT conversion assay was used to determine the cell viability under each treatment condition [@bib19]. The MTT assay relies primarily on the mitochondrial metabolic capacity of viable cells and reflects the intracellular redox state. After incubation, the cells were treated with the MTT solution (final concentration: 1 mg/mL) for 3 h. The dark blue formazan crystals formed in intact cells were solubilized with lysis buffer \[20% (w/v) sodium dodecyl sulfate in 50% (v/v) aqueous N, N dimethyl formamide with an adjusted pH of 4.5\]. The optical density of each well was measured with a 96-well microplate spectrophotometer (Bio-Rad, Hercules, CA, USA, Benchmark) at the test wavelength of 570 nm.

#### 2.4.1.2. Assay of hydroxyl radical scavenging and total antioxidant activity {#sec2.4.1.2}

DPPH radical-scavenging, Ferric-reducing antioxidant power (FRAP) and phosphomolybdenum complex methods were used to evaluate the hydroxyl radical scavenging and total antioxidant capacity of the samples [@bib20]. Five different concentrations (100, 200, 300, 400 and 500 μg/ml) of methanol extract viz., MECD, MECT, MECP and MEEA were used. Vitamin E was used as reference standard for all the three methods.

#### 2.4.1.3. Acetylcholinesterase inhibition microplate assay {#sec2.4.1.3}

AchE activity was measured using a 96-well microplate reader based on Ellman\'s method. The absorbance was measured at 405 nm at every 13 s for 65 s. 25 μL of 0.22 U/ml of AchE enzyme was added and the absorbance was again read at every 13 s for 104 s using 680 XR Microplate Reader S/N 10519 [@bib21]. Percentage inhibition was calculated by comparing the sample to the blank. Ranges of different concentration (50, 100, 150, 200 and 250 μg/ml) of methanol extracts (MECD, MECT, MECP and MEEA) were used. Galantamine was used as reference standard for the study.

#### 2.4.1.4. Lipooxygenase (LOX) enzyme inhibition assay {#sec2.4.1.4}

LOX enzyme inhibition assay was performed using linoleic acid as substrate and lipoxidase as enzyme. Methanol extract of each variety were dissolved separately in 0.25 ml of 2 M borate buffer (pH 9.0) and 0.25 ml of lipoxidase enzyme solution (20,000 U/ml) was added and incubated for 5 min at 25 °C. Further, 1 ml of linoleic acid solution (0.6 mM) was added, mixed well and absorbance was measured at 234 nm. Different concentrations (50, 100, 150, 200 and 250 μg/ml) of the test extracts were plotted to determine the IC~50~ values. Rutin was used as reference standard [@bib21].

### 2.4.2. In vivo studies {#sec2.4.2}

#### 2.4.2.1. Animals {#sec2.4.2.1}

Male Sprague--Dawley rats (wt. 200--250 g, age 2--3 months) were used for the study. The animals were housed in groups of six in polypropylene cages, under standard laboratory conditions of temperature (25 ± 2 °C), lighting (08:00--20:00 h) and relative humidity (50 ± 5%) and had free access to standard pellet chow (Brooke Bond-Lipton, India) and water. Animals were acclimatized for 7 days before initiation of the study. All the experiments were conducted between 0900 and 1400 h. Experimental protocol was approved by Institutional Animal Ethics Committee (IAEC) of B.R. Nahata College of Pharmacy, Mandsaur (Reg. No. 918/ac/05/CPCSEA).

#### 2.4.2.2. Assessment of nootropic activity by scopolamine induced amnesia {#sec2.4.2.2}

The nootropic activity was assessed using Cook and Weidley\'s pole climbing apparatus and Morris water maze task. The animals were divided into seven groups (n = 6). Group I received the vehicle (distilled water) only, Group II received scopolamine (0.3 mg/kg i.p) as negative control, Group III received piracetam (100 mg/kg p.o.) as positive control, and Group IV-VII received methanol extracts (400 mg/kg p.o.) of CD, CT, CP and EA.

#### 2.4.2.3. Cook and Weidley\'s pole climbing apparatus {#sec2.4.2.3}

Briefly, Cook and Weidley\'s pole climbing apparatus [@bib21] consists of a soundproof transparent experimental chamber with a grid floor and a provision of electric current to be considered as shock zone which was initiated with a buzzer tone. The chamber had a transparent covering lid to which a wooden pole screwed into the inner surface, acted as the shock-free zone (Medicraft Electromedicals Pvt Ltd., India). The condition of stimulus was a foot shock of 0.75 mA given to each rat for a period of 2 s from the electrified grid floor, in order to teach them to avoid electric current by climbing on the wooden pole i.e. the shock free zone. Three trial sessions interspersed with an interval of 10 s were conducted daily. During each of the trials, the rats were allowed to explore the apparatus for 10 s, including 2 s foot shock period. Sensitivity of the rats towards foot shock was measured and only those rats, which were sensitive to the shock and could climb the pole, were included in the experiment. The test drugs and vehicle were administered orally once daily for 14 days before commencement of experiment. All the groups were trained daily for learning. Training trial (TT) was conducted after 7 days of treatment. Twenty-four hours later, on day 8, a retention trial (RT) was conducted and the number of avoidance responses (ARs) in the 10 trial sessions were noted. On day 9 of the experiment, after attaining complete training, all the animals except control, were treated with a single dose of scopolamine (0.3 mg/kg i.p.), 30 min before the administration of the extracts. Training schedule was continued further with daily dosing of test drugs till 15 days, for the complete evaluation of the memory retention in terms of retention trial.

#### 2.4.2.4. Morris water maze task {#sec2.4.2.4}

The Morris water maze was described as forced swimming performance of animals in the presence of hidden platform. The first experimental day was dedicated to four swimming training sessions of 60 s in the presence of the platform. On the 2nd day, the rats were given four trial sessions with the platform in place. The time interval between each trial sessions was 30 min. For eight trial sessions, rats were placed every time in the water facing the pool wall in one of the pool quadrants. The entry point was changed in a different order on daily basis. When a rat located the platform, it was permitted to remain on it for 10 s. If the rat did not locate the platform within 60 s, it was placed on the platform for 10 s. After each trial, the wet animal was returned to a cage, dried with towel, and allowed to dry up under an infrared lamp. During each trial session, the time taken to find the hidden platform (latency) was recorded. After the last training trial session, the platform was removed from the pool and rats were allowed to swim for 60 s to search for it. A record was kept of the number of crossing over the platform position in the pool quadrant where the platform had been previously placed. The test drugs and the vehicle were administered orally once daily for 14 days. On the 14 day, a single dose of scopolamine (0.3 mg/kg i.p.) was administered 45 min before the Morris water maze test began. All the groups, except the vehicle treated, received scopolamine. Then, the rats were exposed to training sessions using Morris water maze for two consecutive days before decapitation. The maximum drug concentration occurs approximately 30 min after scopolamine administration [@bib22].

2.5. Data analysis {#sec2.5}
------------------

All the analyses were carried out in triplicate and the results were expressed as mean ± SEM. Regression analysis was used to calculate IC~50~, defined as the concentration of inhibitor necessary for 50% inhibition of the enzyme reaction. For animal studies, the data were expressed as mean ± SEM and analyzed by one-way ANOVA followed by Bonferroni multiple comparison post-test. P and F values and degrees of freedom were calculated. The data was analyzed using GraphPad Prism 5 software (GraphPad Software Inc., La Jolla, California).

3. Results {#sec3}
==========

3.1. Characterization of extract {#sec3.1}
--------------------------------

HPTLC studies revealed the presence of various phytochemicals shown in [Table 1](#tbl1){ref-type="table"}, as reported and published in our earlier studies and may be utilized for phytochemical differentiation among four varieties of *Shankhpushpi* [@bib9], [@bib15], [@bib16], [@bib17].Table 1Characterization of each methanol extract of *Shankhpushpi* botanicals viz. MECD, MECT, MECP and MEEA respectively.Table 1MECDMECTMECPMEEAStigmasterolStigmasterolStigmasterolStigmasterolUrsolic acidLupeolScopoletinBetulinic acidMangiferinUrsolic acidScopoletinScopoletinScopoletin*β*-carotene*β*-carotene*β*-caroteneChlorogenic acidRutin

3.2. β-amyloid induced neuroprotection on brain cell line {#sec3.2}
---------------------------------------------------------

The toxicity of Aβ~1--40~ on Neuro-2a cells was assessed by MTT assay. It was confirmed that when Neuro-2a cells were exposed to Aβ~1--40~ (0.1 μM, 0.5 μM, 1 μM, 5 μM, 10 μM and 15 μM) for 24 h, the rate of MTT reduction was decreased in a concentration-dependent manner ([Fig. 1](#fig1){ref-type="fig"}). Therefore, a fixed concentration of Aβ~1--40~, 2.5 μM, was used for the determination of Aβ~1--40~-induced Neuro-2a cells damage. Neuro-2a cells were incubated in culture medium containing 2.5 μM Aβ~1--40~ with or without test extracts viz. MECD, MECT, MECP, MEEA. As shown in [Fig. 2](#fig2){ref-type="fig"}, MEEA and MECD significantly protected Neuro-2a cells from the cytotoxic effect of Aβ~1--40~. After 24 h exposure to 2.5 μM Aβ~1--40~ alone, the degree of reduction of MTT by Neuro-2a cells was decreased and MEEA and MECD significantly increased cell viability. Further analysis revealed that the protective effects of MEEA and MECD were significantly better than MECT and MECP ([Fig. 2](#fig2){ref-type="fig"}).Fig. 1Characterization of Aβ~1--40~-induced neuronal death in Neuro-2a cells. Cell viability at 24 h was determined by measuring the ability to reduce MTT as a percentage of the ability of control cells. Results are the mean ± SEM. (n = 3), \*\*\**p* \< 0.001 compared with control group without Aβ~1--40.~Fig. 1Fig. 2Effect of methanol extract of various *Shankhpushpi* botanicals on Aβ~1--40~-induced Neuro 2A cell death. Neuro 2A cells were incubated in culture medium containing 10 μM Aβ~1--40~ with or without the following extracts: MECD, MECT, MECP and MEEA. Cell viability at 24 h was determined by measuring the ability to reduce MTT as a percentage of the ability of control cells. The results are the mean ± SEM (n = 3). One-way ANOVA followed by Bonferroni multiple comparison test \[\*\*\**p* \< 0.001, \*\**p* \< 0.01, \**p* \< 0.05; F = 26.59, df (5, 30) = 35\].Fig. 2

3.3. Assay of hydroxyl radical scavenging and total antioxidant activity {#sec3.3}
------------------------------------------------------------------------

Radical scavenging effects and total antioxidant activity of methanol extracts (MECD, MECT, MECP and MEEA) are represented in [Table 2](#tbl2){ref-type="table"}. Results revealed that MEEA possesses highest radical scavenging effect as compared to others, with IC~50~ value of 18.21 ± 0.51 in DPPH method. MEEA also possessed higher antioxidant potential with IC~50~ value of 20.38 ± 0.37 by FRAP (ferric-reducing antioxidant power) and 20.63 ± 0.30 μg/ml by phosphomolybdenum complex method. The order of activity was found to be MEEA\>MECD\>MECP\>MECT in all the three methods.Table 2Comparative antioxidant and hydroxyl radical scavenging activity of methanol extract of various *Shankhpushpi* botanicals.Table 2TreatmentsIC~50~ value (μg/ml)DPPHFRAPPhosphomolybdenumVitamin E13.62 ± 2.0312.39 ± 0.174.41 ± 0.08MECD19.15 ± 0.35^ns^21.65 ± 0.15\*\*\*21.62 ± 0.40\*\*\*MECT36.09 ± 2.10\*\*\*66.71 ± 1.28\*\*\*24.64 ± 1.73\*\*\*MECP25.46 ± 0.08\*\*26.94 ± 0.14\*\*\*22.11 ± 0.41\*\*\*MEEA18.21 ± 0.51^ns^20.38 ± 0.37\*\*\*20.63 ± 0.30\*\*\*[^1]

3.4. Acetylcholinesterase inhibition microplate assay {#sec3.4}
-----------------------------------------------------

MEEA showed appreciably higher activity than other three varieties and inhibited AchE with an IC~50~ value of 65.67 ± 11.32 μg/ml ([Table 3](#tbl3){ref-type="table"}). Galantamine was used as a positive control, showed inhibition with an IC~50~ value of 4.68 ± 0.16 μg/ml. The order of activity was found to be MEEA\>MECD\>MECP\>MECT.Table 3Comparative acetylcholinesterase (AchE) and lipoxygenase (LOX) inhibitory activity of methanol extract of various *Shankhpushpi* botanicals.Table 3TreatmentsIC~50~ value (μg/ml)AchELOXRutin^A^Not applicable4.21 ± 0.17Galantamine^B^4.68 ± 0.16Not applicableMECD65.88 ± 3.78\*28.39 ± 1.24\*\*\*MECT132.40 ± 18.96\*\*\*114.35 ± 0.99\*\*\*MECP107.99 ± 7.57\*\*81.76 ± 2.07\*\*\*MEEA65.67 ± 11.32\*19.04 ± 0.78\*\*\*[^2]

3.5. Lipooxygenase (LOX) enzyme inhibition assay {#sec3.5}
------------------------------------------------

Among all the tested methanol extracts, MEEA showed highest activity and inhibited LOX enzyme with the IC~50~ value of 19.04 ± 0.78 μg/ml ([Table 3](#tbl3){ref-type="table"}). Rutin was used as a positive control, showed inhibition with an IC~50~ value of 4.21 ± 0.17 μg/ml. The order of activity was found to be MEEA\>MECD\>MECP\>MECT.

3.6. Assessment of nootropic activity by scopolamine induced amnesia {#sec3.6}
--------------------------------------------------------------------

Inhibitory avoidance test conducted by administration of scopolamine induced amnesia resulted in reduction in the number of avoidance responses. However, continued treatment of MEEA produced better retention and recovery as compared to the extracts of other three varieties.

### 3.6.1. Cook and Weidley\'s pole climbing apparatus {#sec3.6.1}

There was a significant increase in memory retention and retrieval in MEEA treated groups. The order of activity was found to be MEEA\>MECD\>MECP\>MECT. A one-way ANOVA followed by Bonferroni\'s multiple comparison post-test, conducted on the avoidance response of rats when they were administered a single dose of scopolamine on 9th day followed by trials on 10th, 11th, 12th, 13th, 14th and 15th day demonstrated that the *Shankhpushpi* extract treated groups exhibited a significant \[\*\*\*\**p* \< 0.0001, \*\*\**p* \< 0.001, \*\**p* \< 0.01; F = 114.1; df (4, 40) = 44\] increase in the number of ARs as compared to the scopolamine and vehicle treated groups ([Fig. 3](#fig3){ref-type="fig"}). The order of activity was found to be MEEA\>MECD\>MECP\>MECT.Fig. 3Effect of methanol extract of various *Shankhpushpi* botanicals on nootropic activity by scopolamine induced amnesia in rats using Cook and Weidley\'s pole climbing apparatus. All values are mean ± SEM (n = 6). One-way ANOVA followed by Bonferroni multiple comparison tests \[\*\*\**p* \< 0.0001, \*\*\**p* \< 0.001, \*\**p* \< 0.01; F = 114.1; df (4, 40) = 44\].Fig. 3

### 3.6.2. Morris water maze task {#sec3.6.2}

The data in [Table 4](#tbl4){ref-type="table"} shows the comparative improvement in memory-dependent learning by treatment with methanolic extracts. MEEA revealed comparative significant higher increase in latency time in scopolamine treated rats in comparison with others and the corresponding control \[\*\*\*\**p* \< 0.0001; \*\*\**p* \< 0.0005; \*\**p* \< 0.005; \**p* \< 0.05; F = 14.42; df (6, 35) = 41\]. All the extract treated groups exhibited decrease in the latency time as compared to the corresponding scopolamine treated rats. These rats showed a significant decrease in number of crossings over the platform position as compared to the corresponding control. The order of activity was found to be MEEA\>MECD\>MECP\>MECT.Table 4Effect of methanol extract of various *Shankhpushpi* botanicals on scopolamine induced amnesia by Morris water maize test.Table 4Treatment\#\
(mg/kg)Escape Latency60 Seconds^a^Crossing the platform in 7 trials^b^Vehicle32.89 ± 6.74\*\*\*\*5.66 ± 0.33\*\*\*\*Scopolamine48.52 ± 0.251.66 ± 0.33Piracetam19.22 ± 0.21\*\*\*\*6.33 ± 0.33\*\*\*\*MECD26.03 ± 0.07\*\*\*\*4.66 ± 0.33\*\*\*\*MECT36.05 ± 0.12\*2.33 ± 0.33nsMECP30.02 ± 0.09\*\*\*2.66 ± 0.33nsMEEA23.08 ± 0.02\*\*\*\*5.33 ± 0.33\*\*\*\*[^3]

4. Discussion {#sec4}
=============

Synonymous use of the word '*Shankhpushpi*' for different varieties creates a controversy regarding their identity which often results in the use of less potent variety in herbal formulations [@bib23]. The present work provides comparative neuropharmacological evaluation, which was needed to identify most suitable memory enhancer among them. Although all plants are individually tested and found active in various parameters involving *in vitro* and *in vivo* experiments, still, they differ in their pharmacological effectiveness.

Many of the phytochemicals present in *Shankhpushpi* are reported individually to possess activities related to antioxidant action, memory dysfunction and CNS stimulation [@bib24], [@bib25]. Presence and absence of such phytochemicals in different varieties of *Shankhpushpi* creates confusion as to which is the most potent variety [@bib8].

It was reported that *β*-amyloid peptides have been used to initiate neurotoxicity in Neuro-2a (a neuroblastoma cell lines) cultured cells [@bib26]. The toxic effects of *β*-amyloid peptides as found in our studies ([Fig. 2](#fig2){ref-type="fig"}) agree with previously reported data in neuronal cells [@bib27]. MTT assay was reported to measure protective effects of plant extracts and compounds on cell viability. In order to determine and compare the effect of four varieties against Aβ~1--40~ induced neurotoxicity, MTT based cell protection assay was performed. The order of cell protection against Aβ~1--40~ induced neurotoxicity damage was found to be MEEA\>MECD\>MECP\>MECT ([Fig. 2](#fig2){ref-type="fig"}). These data support the neuroprotective activity of tested drugs by reducing β-amyloid deposition in the brain to protect from memory dysfunction.

It has been established earlier that brain aging is mainly associated with free radical action [@bib28]. In the present study, comparative free radical scavenging and total antioxidant capacities of four *Shankhpushpi* botanicals were measured by using the DPPH, FRAP and phosphomolybdenum method reaction. The order of activity was found to be MEEA\>MECD\>MECP\>MECT in all the three methods performed. These data supports neuroprotective activity of tested drugs, underlying mechanism being free radical scavenging and antioxidant action on the brain cells, providing protective action against memory dysfunction.

Disturbance of cholinergic neurotransmission in the brain contributes to the salient cognitive decline and progression of memory dysfunction [@bib29], [@bib30]. Present study depicts that all the four *Shankhpushpi* botanicals inhibited AchE significantly and protected the loss of neurotransmitter AchE, which is directly responsible for cognitive function. The order of activity was found to be MEEA\>MECD\>MECP\>MECT.

It was reported earlier that 5-lipooxygenase is a key enzyme in the biosynthesis of leukotriene, which has been postulated to play an important role in the pathophysiology of aging-associated neurodegenerative disorders [@bib31]. Present study revealed that all the four *Shankhpushpi* botanicals inhibited 5-LOX significantly, which is directly responsible for neurodegenerative disorders. The order of activity was found to be MEEA\>MECD\>MECP\>MECT.

We further confirmed our findings from *in vitro* studies by adopting various animal protocols reported earlier for evaluation of nootropic activity. We assessed nootropic activity by Cook and Weidley\'s pole climbing apparatus and Morris water maze task on scopolamine induced amnesia model. It was seen that animals receiving only scopolamine on day 9 (Cook and Weidley\'s pole climbing apparatus) and day 14 (Morris water maze task) showed a considerable loss of memory and amnesia produced was persistent. There is substantial evidence that muscarinic receptor blockade by drugs like scopolamine results into disruptions of various tasks related to performance of memory [@bib32], [@bib33]. Reduction in the number of avoidance responses is an evidence of amnesia during inhibitory avoidance test conducted after administration of scopolamine. However, it is evident in our experiments that continued treatment with methanol extracts of four *Shankhpushpi* botanicals individually produced better retention and recovery. The order of activity in both the performed *in vivo* task was found to be MEEA\>MECD\>MECP\>MECT, which is similar to the *in vitro* findings.

Thus, anti-amensic effects of *Shankhpushpi* on scopolamine induced amnesia by utilizing Cook and Weidley\'s pole climbing apparatus and Morris water maze task were successfully demonstrated through the study. EA was proven to be most potent for memory and related disorders in many of previous studies [@bib7], [@bib12], [@bib34]. EA possessed higher activity than other as an evidence from all the experiments performed in present studies.

5. Conclusion {#sec5}
=============

The findings validate that the traditional use of *Shankhpushpi* for its neuropharmacological action and provide great relevance for its use in the prevention and therapies of memory and CNS related dysfunctions. The comparative multiple beneficial effects of *E. alsinoides* over other *Shankhpushpi* botanicals makes it a promising agent for controlled clinical trials to establish its safety and efficacy as an antioxidant, NSAID-like prophylactic agent, NMDA down-regulator and acetylcholinesterase enhancer for protection against AD and possibly other neurodegenerative age-related diseases. The results of neuropharmacological activity suggest that *E. alsinoides* should be used as the true source of *Shankhpushpi* while the other three plants can be used as its substitutes.
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[^1]: All values are mean ± SEM (n = 6). One-way ANOVA followed by Bonferroni post-tests regardless of all p-values. ^ns^*p* \> 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001 compared to Vitamin E for all three separate experiment.

[^2]: Where 'A' is used as positive control for LOX and 'B' is used as positive control for AchE. All values are mean ± SEM (n = 6). One-way ANOVA followed by Bonferroni post-tests regardless of all p-values. ^∗^*p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001 compared to galantamine for AchE and rutin for LOX.

[^3]: The test drugs and the vehicle were administered orally once daily for 14 days. On the 14 day, a single dose of scopolamine (0.3 mg/kg i.p.) was administered 45 min before the moris water maze began. All the groups, except the vehicle treated, received scopolamine. One-way ANOVA followed by Bonferroni multiple comparison tests. All values are mean ± SEM (n = 6). \[\*\*\*\**p* \< 0.0001; \*\*\**p* \< 0.0005;\*\**p* \< 0.005; \**p* \< 0.05; F = 14.42; df (6, 35) = 41\].
